Micron Technology
Courtesy of Micron Technology

Thanks, in large part, to dealmaking, these 5 giants saw dramatic revenue growth worthy of tech startups.

By Phil Wahba
June 16, 2015

There’s a reason mergers and acquisitions activity spiked 45% in 2014 to hit $3.5 trillion: dealmaking, facilitated by low borrowing costs, helps America’s Fortune 500 companies boast dramatic revenue growth worthy of tech startups.

Indeed, M&A accounts for four of the five biggest sales jumps in the Fortune 500: Spartan Stores, a Midwest grocery distributor, tripled its revenue and expanded beyond its midwestern stronghold, by buying Nash Finch and becoming SpartanNash, now the largest wholesaler serving U.S. military commissaries. NGL Energy Partners and Devon Energy continued their years of dealmaking by buying smaller rivals, or their key assets, while chipmaker Micron Technology became a giant in the flash memory chips market by buying Elpida.

One company high on the list that achieved heady growth organically was biotech company Gilead, whose hepatitis blockbuster drugs doubled its revenue last year.

But few companies other than biotech or IT companies can hope to pull off such a feat, so it looks like M&A will remain the main tool for such outsized growth by Fortune 500 companies. And so far in 2015, the pace of dealmaking suggest that’s exactly what they’re doing.


1. SpartanNash

Courtesy of SpartanNash

SpartanNash  SPTN is the product of the late 2013 merger between Spartan Stores and Nash-Finch that created a leading wholesaler of grocery to military commissaries and food retailers, along with its own chain of 162 stores in the Midwest under different banners.

The combined company’s came to $7.9 billion in 2014, more than triple what Spartan made on its own. Though the company is now bigger and has more clout, it also is competing for businesses that offer the tiniest of margins, particularly the military, meaning it will likely need to keep scaling up.


2. Gilead Sciences

Courtesy of Gilead Sciences

Gilead Sciences GILD sold $10.3 billion of its new hepatitis C drug, Sovaldi, last year, almost enough to make it the best-selling drug in the world in its first year on the market, and practically doubling company sales on its own. (Overall, revenue rose 122.2% to $24 billion.)

The biotech company later launched an even newer hepatitis C drug, Harvoni, that generated another $2 billion. But health plans are trying to pit Gilead against AbbVie, which introduced its own hepatitis C treatment, Viekira Pak, last year in a bid to contain costs.

Still, after a strong start to the year, Gilead raised its sales outlook for 2015 and now expects to rake in up to $29 billion this year.


3. NGL Energy Partners

Courtesy of NGL Energy Partners

NGL Energy Partners NGL is a diversified company that owns facilities ranging from crude oil storage terminals, pipeline injection stations, a trucks, water treatment and disposal facilities, and a business that supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants throughout Canada and the U.S.

NGL’s revenue, which grew 119.6% last year to $9.7 billion, thanks in large part to a bunch of acquisitions, such as its late 2014 acquisition of Gavilon Energy, which owned crude oil terminals in Oklahoma, Texas, and Louisiana that broadened its geographic reach. And with lower energy prices expected to set off more consolidation in the industry, it wouldn’t be surprising to see NGL continue its shopping spree in 2015.

 

 

 


4. Devon Energy

Courtesy of Devon Energy

Devon Energy  DVN is one of the biggest independent natural gas and oil producers in the U.S, focused on North American onshore exploration and production.

Its 88% jump in revenue to $19.6 billion last year came from a number of big acquisitions, including a $6 billion deal to buy some oil and gas properties and leasehold mineral interests from GeoSouthern Energy. But even as it plans to continue dealmaking, Devon warned investors in its annual report that low energy prices could hurt its business in 2015.


5. Micron Technology

Courtesy of Micron Technology

Micron Technology’s MU revenue rose 80.3% last year to $16.4 billion thanks to its mid-2013 acquisition of Elpida, which made it the second biggest producer of dynamic random access memory (DRAM), a key part in personal computers. (Samsung is the biggest producer of DRAM.)  The Boise-based company also become a bigger player in the flash memory chips market, one set to grow as smartphones and tablet computers continue to grow in popularity.

 

To see the full list of the Fortune 500, visit Fortune.com/Fortune500

SPONSORED FINANCIAL CONTENT

You May Like